Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupreme Plc Regulatory News (SUP)

Share Price Information for Supreme Plc (SUP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 130.50
Bid: 129.00
Ask: 132.00
Change: 0.50 (0.38%)
Spread: 3.00 (2.326%)
Open: 130.00
High: 130.50
Low: 130.00
Prev. Close: 130.00
SUP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Sealions Vitamin brand

19 Jul 2021 07:00

RNS Number : 5614F
Supreme PLC
19 July 2021
 

19 July 2021

 

Supreme plc

("Supreme," the "Company" or the "Group")

 

Launch of Sealions Vitamin brand

 

Supreme (AIM:SUP), a leading manufacturer, supplier, and brand owner of fast-moving consumer products, is pleased to announce the launch of its digital-only UK health and wellness brand, Sealionsoffering accessible vitamin and wellness supplements for all ages.

 

Sealions will be focused on providing a high-quality range of affordable wellness products, offering customers a year's supply of vitamins (365 tablets) for £5 across a selected range, nearly 70% cheaper than some of the leading wellness brands.

 

Available to purchase online at www.sealions.com, Sealions' products have been created in the UK by BRCGS-accredited suppliers and are packaged in compostable, plastic-free pouches. Sealions offers a core range of products, including Vitamin D3 1000iu, Vitamin C 200mg, A-Z Multivitamin, Fish Oil 1000mg and Cod Liver Oil 1000mg.

 

Sandy Chadha, Chief Executive Officer of Supreme, commented:

"We are delighted to be officially launching Sealions vitamins and wellness brand, which we believe has the potential to accelerate our market penetration in what we believe is a very exciting growth vertical for Supreme.

"Today's announcement is another excellent example of how we will seek to expand our market footprint through organic growth initiatives centred on customer and brand loyalty."

 

Enquiries:

 

Supreme plc

Sandy Chadha, Chief Executive Officer

Suzanne Smith, Chief Finance Officer

 

via Vigo Consulting

 

Grant Thornton UK LLP (Nominated Adviser)

Philip Secrett / Samantha Harrison / Harrison Clarke 

 

+44 (0)20 7383 5100

Berenberg (Broker)

Chris Bowman / Mark Whitmore / Jen Clarke

 

+44 (0)20 3207 7800

Vigo Consulting (Financial Public Relations)

Jeremy Garcia / Antonia Pollock

supreme@vigoconsulting.com

+44 (0)20 7390 0230

 

 

About Supreme

 

Supreme supplies products across five key categories; batteries, lighting, vaping, sports nutrition & wellness, and branded household consumer goods. The Company's capabilities span from product development and manufacturing through to its extensive retail distribution network and direct to consumer capabilities. This vertically integrated platform provides an excellent route to market for well-known brands and products.

 

The Group has over 3,300 active business accounts with retail customers who manage over 10,000 branded retail outlets. Customers include B&M, Home Bargains, Poundland, The Range, Londis, SPAR, Costcutter, Asda, Morrisons, McColl's, Halfords, Iceland and HM Prison & Probation Service.

 

In addition to distributing globally-recognised brands such as Duracell, Energizer and Panasonic, and supplying lighting products exclusively under the Energizer, Eveready and JCB licences across 45 countries, Supreme has also developed brands in-house, most notably 88Vape and has a growing footprint in Sports Nutrition and Wellness.

 

www.investors.supreme.co.uk 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASFFFLMEFSESW
12
Date   Source Headline
31st May 20247:00 amRNSTotal Voting Rights
24th Apr 20247:00 amRNSYear End Trading Update
28th Mar 20247:00 amRNSTotal Voting Rights
22nd Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Feb 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Feb 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Feb 20247:00 amRNSCommencement of Share Buyback Programme
29th Jan 20242:42 pmRNSMarket and Trading Update and Share Buyback
5th Jan 20247:00 amRNSAcquisition of protein manufacturing assets
2nd Jan 20247:00 amRNSBlock Admission Return
29th Dec 20237:00 amRNSTotal Voting Rights
1st Dec 20238:58 amRNSGrant of Options and Director Dealing
28th Nov 20237:00 amRNSHalf-year Results
31st Oct 20237:00 amRNSTotal Voting Rights
23rd Oct 20237:00 amRNSAppointment of Nomad and Joint Brokers
18th Oct 20237:01 amRNSVaping Category Update
18th Oct 20237:00 amRNSTrading Statement & Notice of Results
4th Oct 202310:50 amRNSDirector Share Purchase
26th Sep 202312:07 pmRNSResult of AGM
26th Sep 20237:00 amRNSAGM Trading Statement
13th Sep 20238:31 amRNSResponse to Media Speculation
23rd Aug 20237:00 amRNSAvailability of Annual Report & Notice of AGM
5th Jul 20237:01 amRNSSignificant Vaping Distribution Appointment
5th Jul 20237:00 amRNSFinal Results
3rd Jul 20237:00 amRNSBlock Admission of Shares
19th Jun 20239:30 amRNSNotice of Results & Investor Presentation
15th May 20233:07 pmRNSDirector Share Purchase
28th Apr 20237:00 amRNSTotal Voting Rights
20th Apr 202311:56 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSYear End Trading Update
31st Mar 20237:00 amRNSTotal Voting Rights
14th Mar 20232:30 pmRNSDisposal of the IP of T-Juice
28th Feb 202312:34 pmRNSTotal Voting Rights
19th Jan 20237:00 amRNSBlock Admission of Shares
13th Jan 20237:00 amRNSHolding(s) in Company
10th Jan 20232:05 pmRNSSecond Price Monitoring Extn
10th Jan 20232:00 pmRNSPrice Monitoring Extension
10th Jan 20237:00 amRNSStrong Q3 Trading
29th Nov 20227:00 amRNSHalf-year Results
24th Oct 20227:00 amRNSTrading Update and Notice of Results
15th Sep 20225:08 pmRNSResult of AGM
15th Sep 20227:00 amRNSAGM Statement
22nd Aug 202211:06 amRNSSecond Price Monitoring Extn
22nd Aug 202211:00 amRNSPrice Monitoring Extension
15th Aug 20227:00 amRNSAvailability of Annual Report & Notice of AGM
9th Aug 20227:00 amRNSAcquisition of Cuts Ice/Flavour Core trade/assets
8th Aug 20227:00 amRNSGrant of performance share awards to a PDMR
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.